APA引文

Manouchehri, N., & Stüve, O. (2021). Should ocrelizumab be used in non-active primary progressive multiple sclerosis? Time for a re-assessment. Ther Adv Neurol Disord.

Citação norma Chicago

Manouchehri, Navid, and Olaf Stüve. "Should Ocrelizumab Be Used in Non-active Primary Progressive Multiple Sclerosis? Time for a Re-assessment." Ther Adv Neurol Disord 2021.

MLA引文

Manouchehri, Navid, and Olaf Stüve. "Should Ocrelizumab Be Used in Non-active Primary Progressive Multiple Sclerosis? Time for a Re-assessment." Ther Adv Neurol Disord 2021.

警告：這些引文格式不一定是100％准確.